Cargando…
Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393970/ https://www.ncbi.nlm.nih.gov/pubmed/37528138 http://dx.doi.org/10.1038/s41598-023-39545-0 |
| _version_ | 1785083262005149696 |
|---|---|
| author | Li, Kai Ma, Lei Sun, Ye Li, Xiang Ren, Hong Tang, Shou-Ching Sun, Xin |
| author_facet | Li, Kai Ma, Lei Sun, Ye Li, Xiang Ren, Hong Tang, Shou-Ching Sun, Xin |
| author_sort | Li, Kai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10393970 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103939702023-08-03 Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas Li, Kai Ma, Lei Sun, Ye Li, Xiang Ren, Hong Tang, Shou-Ching Sun, Xin Sci Rep Author Correction Nature Publishing Group UK 2023-08-01 /pmc/articles/PMC10393970/ /pubmed/37528138 http://dx.doi.org/10.1038/s41598-023-39545-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Li, Kai Ma, Lei Sun, Ye Li, Xiang Ren, Hong Tang, Shou-Ching Sun, Xin Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas |
| title | Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas |
| title_full | Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas |
| title_fullStr | Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas |
| title_full_unstemmed | Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas |
| title_short | Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas |
| title_sort | author correction: the immunotherapy candidate tnfsf4 may help the induction of a promising immunological response in breast carcinomas |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393970/ https://www.ncbi.nlm.nih.gov/pubmed/37528138 http://dx.doi.org/10.1038/s41598-023-39545-0 |
| work_keys_str_mv | AT likai authorcorrectiontheimmunotherapycandidatetnfsf4mayhelptheinductionofapromisingimmunologicalresponseinbreastcarcinomas AT malei authorcorrectiontheimmunotherapycandidatetnfsf4mayhelptheinductionofapromisingimmunologicalresponseinbreastcarcinomas AT sunye authorcorrectiontheimmunotherapycandidatetnfsf4mayhelptheinductionofapromisingimmunologicalresponseinbreastcarcinomas AT lixiang authorcorrectiontheimmunotherapycandidatetnfsf4mayhelptheinductionofapromisingimmunologicalresponseinbreastcarcinomas AT renhong authorcorrectiontheimmunotherapycandidatetnfsf4mayhelptheinductionofapromisingimmunologicalresponseinbreastcarcinomas AT tangshouching authorcorrectiontheimmunotherapycandidatetnfsf4mayhelptheinductionofapromisingimmunologicalresponseinbreastcarcinomas AT sunxin authorcorrectiontheimmunotherapycandidatetnfsf4mayhelptheinductionofapromisingimmunologicalresponseinbreastcarcinomas |